TITLE

Anaphylaxis following quadrivalent human papillomavirus vaccination

AUTHOR(S)
Brotherton, Julia M. L.; Gold, Mike S.; Kemp, Andrew S.; McIntyre, Peter B.; Burgess, Margaret A.; Campbell-Lloyd, Sue
PUB. DATE
September 2008
SOURCE
CMAJ: Canadian Medical Association Journal;9/9/2008, Vol. 179 Issue 6, p525
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In 2007, Australia implemented the National human papillomavirus (HPV) Vaccination Program, which provides quadrivalent HPV vaccine free to all women aged 12-26 years. Following notification of 7 presumptive cases of anaphylaxis in the state of New South Wales, Australia, we verified cases and compared the incidence of anaphylaxis following HPV vaccination to other vaccines in comparable settings. Methods: We contacted all patients with suspected anaphylaxis and obtained detailed histories from telephone interviews and a review of medical records. A multidisciplinary team determined whether each suspected case met the standardized Brighton definition. Some participants also received skin-prick allergy testing for common antigens and components of the HPV vaccine. Results: Of 12 suspected cases, 8 were classified as anaphylaxis. Of these, 4 participants had negative skin-prick test results for intradermal Gardasil. From the 269 680 HPV vaccine doses administered in schools, 7 cases of anaphylaxis were identified, which represents an incidence rate of 2.6 per 100 000 doses (95% CI 1.0-5.3 per 100 000). In comparison, the rate of identified anaphylaxis was 0.1 per 100 000 doses (95% CI 0.003-0.7) for conjugated meningococcal C vaccination in a 2003 school-based program. Interpretation: Based on the number of confirmed cases, the estimated rate of anaphylaxis following quadrivalent HPV vaccine was significantly higher than identified in comparable school-based delivery of other vaccines. However, overall rates were very low and managed appropriately with no serious sequelae.
ACCESSION #
34079894

 

Related Articles

  • GPs want HPV programme expanded. Moberly, Tom // GP: General Practitioner;12/5/2008, p1 

    The article reports on a survey of general practitioners (GPs) in Great Britain concerning their primary care organisations (PCOs) to prevent papillomaviruses. More than half of GPs who participated in the survey said that their PCO had asked them not to vaccinate outside the countrywide...

  • Introduction. Alexander, Kenneth A. // Infectious Diseases in Children;Apr2011 Supplement, p2 

    The author provides a brief overview of the efficacy of human papillomavirus (HPV) vaccination for the prevention of HPV-associated diseases and its expanding use among women and men as well.

  • HPV Vaccine: Evolving Indications and Recommendations. Alexander, Kenneth A. // Infectious Diseases in Children;Apr2011 Supplement, p4 

    The article discusses the facts and the events that led to the expansion of human papillomavirus (HPV) immunization indications in women and men.

  • US committee recommends HPV vaccine for boys. Roehr, Bob // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;11/5/2011, Vol. 343 Issue 7830, p927 

    The article reports on a U.S. committee, which recommended mandatory quadrivalent vaccination to all boys in the U.S. against human papillomavirus (HPV) infection.

  • Knowledge, awareness and utilisation of the human papillomavirus vaccine in Durban. Allie, N.; Moodley, M. // Southern African Journal of Gynaecological Oncology;2012, Vol. 4 Issue 1, p6 

    The article presents a study that demonstrates the knowledge, awareness and utilization of the of the human papillomavirus (HPV) vaccine among healthcare workers in a health district in KwaZulu-Natal in Durban, South Africa. The study found that 89% of healthcare workers were aware of the...

  • Focus on Back to School Health.  // Infectious Diseases in Children;Sep2010, Vol. 23 Issue 9, p15 

    The article presents the recommended immunization schedule for people aged seven through 18 years in the U.S., including those for human papillomavirus vaccine (HPV), pneumococcal polysaccharide vaccine (PPSV) and hepatitis A vaccine (HepA).

  • Clinician recommendation positively linked to male vaccination against HPV.  // Infectious Diseases in Children;Oct2012, Vol. 25 Issue 10, p20 

    The article offers information on research which found a positive association between male vaccination against human papillomavirus and clinician recommendation for the vaccine.

  • Errata.  // MMWR: Morbidity & Mortality Weekly Report;12/12/2014, Vol. 63 Issue 49, p1182 

    A correction to the article "Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)" in journal issue Vol. 63, No. RR-5 is presented.

  • HPV vaccination program linked to decreases in cervical abnormalities in Australian population.  // Hem/Onc Today;7/25/2011, Vol. 12 Issue 14, p23 

    The article reports on results of the HPV vaccination program on the decrease in high-grade cervical abnormalities in Australia.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics